XMSM
GL9
Market cap6.07bUSD
Jun 18, Last price
21.90EUR
1D
2.62%
1Q
31.29%
Jan 2017
38.78%
Name
Glanbia PLC
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Glanbia plc functions as a prominent global entity within the nutrition industry. The company is actively involved in the creation and distribution of a wide array of sports and lifestyle nutrition products, available in diverse formats such as powdered supplements, ready-to-eat bars and snacks, and convenient ready-to-drink beverages. Its extensive distribution channels include specialized retail outlets, online platforms, fitness centers, and major commercial avenues like grocery stores, pharmacies, mass merchandisers, and membership clubs. Beyond consumer products, Glanbia is a significant producer and supplier of cheese, various dairy and plant-based nutritional and functional ingredients, and vital vitamin and mineral premixes. The company's operations further extend into areas such as financing, research and development, real estate transactions, receivables management, property leasing, and offering weight management solutions, in addition to other business and management services. Glanbia maintains a strong portfolio of brands, featuring well-known names like OPTIMUM NUTRITION, SlimFast, BSN, ISOPURE, NUTRAMINO, think!, Amazing Grass, and BODY&FIT. The company, which was established in 1964, has its corporate headquarters situated in Kilkenny, Ireland.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||